Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital
This research project is looking back at how doctors used a pain medicine called intranasal fentanyl (a nasal spray) for children who came to the emergency department with bone or muscle pain, like from an injury. Many studies have already shown this nasal spray is good at treating pain and is safe to use. Because of this, many emergency departments have started using it. This study at Strasbourg University Hospital wants to see how well the nasal spray was prescribed and how its use was looked after in practice for children treated between August 2022 and September 2024. The aim is to understand current practice better so that doctors can continue to provide the best possible pain relief for children in emergencies.
At a glance
What is this study about?
When children come to the emergency department with pain, especially from injuries affecting their bones or muscles, it's really important to help them feel better quickly. One way doctors have been doing this recently is by using a pain-relieving nasal spray called intranasal fentanyl. This medicine has been shown in other studies to be effective and safe for children.
This particular study, taking place at Strasbourg University Hospital, isn't about trying a new treatment. Instead, it's looking back at information from children's medical records who have already been treated with this nasal spray between August 2022 and September 2024. The doctors want to understand how the nasal spray was given and how closely children were monitored after receiving it in their emergency department.
The main goal of this research is to see if the nasal spray was prescribed correctly and if patients were looked after properly after getting the medicine. By reviewing past treatments, doctors can learn more about how well the current methods are working and make sure they are providing the best possible pain relief for children in the future.
Key takeaways
- This is a 'look-back' study, reviewing past treatments.
- It's examining how a pain-relieving nasal spray was used for children in an emergency department.
- The goal is to improve future pain management for children.
- No new treatments or patient involvement are required.
- Your child's privacy will be protected.
Who may be eligible?
This study is looking at medical records of children who have already received treatment. This means you wouldn't directly 'join' this study as a participant in the traditional sense, but rather your child's past medical information might be reviewed if they meet certain criteria.
Your child's information might be included if they were under 18 years old and were treated in the children's emergency department at Strasbourg University Hospital. They also needed to have received the intranasal fentanyl nasal spray between 1st August 2022 and 30th September 2024. Finally, your child (or you, as their parent or guardian) must not have told the hospital that you don't want their health information to be used for research purposes after being informed about it.
Information would not be included if you or your child refused to have their data used, if parts of their medical record were missing, or if they didn't live in France.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Was your child under 18 when treated?
- Did they receive treatment in the children's emergency department at Strasbourg University Hospital?
- Did they receive the fentanyl nasal spray between August 2022 and September 2024?
- Did you or your child give permission for their health data to be used for research?
What does participation involve?
As this study is looking back at existing medical records, there is no direct participation required from you or your child. This means no extra hospital visits, no new medicines to take, no additional tests, and no follow-up appointments related to this study. The researchers will simply be reviewing anonymised or de-identified information that is already in your child's medical file if they fit the criteria mentioned above. The study's duration for data collection from records is specific to the dates mentioned, but this doesn't impact you directly.
Potential risks and benefits
Locations (1)
- Service d'Urgences Médico-Chirurgicales Pédiatriques - CHU de Strasbourg - FranceVerified postcodeStrasbourg, France· Recruiting
Common questions
What is 'intranasal fentanyl'?
It's a strong pain medicine given as a spray into the nose, often used for children with severe pain in emergency situations.
Is my child being given this medicine as part of the study?
No, this study is looking back at how the medicine was used in children who have already been treated. It doesn't involve giving new medicine.
Will this study affect my child's medical care?
No, this study only reviews past records. It will not change your child's current or future medical care.
How is my child's privacy protected?
The researchers will only look at anonymised or de-identified information, meaning personal details that could identify your child will be removed or protected.
Can I stop my child's records from being used?
Yes, if you or your child (if old enough) did not want their health information used for research, you would have expressed this to the hospital, and their data would not be included.
How to find out more
Dimitar TCHOMAKOV, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.